Sanofi (SNY) Total Current Liabilities (2009 - 2025)

Sanofi has disclosed Total Current Liabilities across 17 years of filings, most recently posting $33.0 billion for Q4 2025.

• Total Current Liabilities for Q4 2025 came in at $33.0 billion, up 5.88% year-over-year; the trailing twelve-month figure through Dec 2025 was $33.0 billion (up 5.88% YoY), and the FY2025 annual result was $33.0 billion, up 5.88% from the prior year.
• Total Current Liabilities came in at $33.0 billion for Q4 2025 at Sanofi, roughly flat from $32.9 billion in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $33.0 billion in Q4 2025 to a low of $23.0 billion in Q2 2021.
• The 5-year median for Total Current Liabilities is $26.5 billion (2023), against an average of $27.8 billion.
• Across the five-year window, Total Current Liabilities advanced 0.4% in 2022 and grew 19.93% in 2024, its largest moves.
• Sanofi's Total Current Liabilities stood at $24.4 billion in 2021, then climbed by 0.4% to $24.5 billion in 2022, then rose by 6.48% to $26.0 billion in 2023, then advanced by 19.65% to $31.2 billion in 2024, then climbed by 5.88% to $33.0 billion in 2025.
• The last three Total Current Liabilities figures came in at $33.0 billion (Q4 2025), $32.9 billion (Q2 2025), and $31.2 billion (Q4 2024), per Business Quant data.